A61K 9/4891
Coated capsules
Official title: {Coated capsules; Multilayered drug free capsule shells (with drug coating for immediate release A61K9/4808; osmotic devices A61K9/0004)}
A61K9/4891 (Coated capsules) appears on 889 US grants and 1,534 published applications in this corpus.
Search patents in A61K- Granted patents
- 889
- Published applications
- 1,534
- Assignees
- 626
- Inventors
- 2,094
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 8 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 17 | 7 |
| 2002 | 10 | 14 |
| 2003 | 8 | 17 |
| 2004 | 10 | 19 |
| 2005 | 2 | 26 |
| 2006 | 8 | 22 |
| 2007 | 2 | 34 |
| 2008 | 3 | 23 |
| 2009 | 11 | 35 |
| 2010 | 8 | 38 |
| 2011 | 30 | 58 |
| 2012 | 28 | 48 |
| 2013 | 38 | 63 |
| 2014 | 36 | 91 |
| 2015 | 41 | 124 |
| 2016 | 60 | 112 |
| 2017 | 61 | 100 |
| 2018 | 68 | 94 |
| 2019 | 45 | 107 |
| 2020 | 65 | 77 |
| 2021 | 62 | 96 |
| 2022 | 51 | 90 |
| 2023 | 36 | 63 |
| 2024 | 52 | 73 |
| 2025 | 36 | 68 |
| 2026 | 20 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Delayed release oral pharmaceutical composition8 Sep 2026US 12,728,097 B2Aihol Corporation
- Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same25 Aug 2026US 12,714,730 B2Persephone Biosciences, Inc.
- Orally administered solid dosage form drug4 Aug 2026US 12,697,306 B2Ascentawits Pharmaceuticals, Ltd.
- Enteric coating composition and method of making and using the same28 Jul 2026US 12,691,075 B2Sensient Colors LLC
- Use of cysteamine and derivatives thereof to suppress tumor metastases30 Jun 2026US 12,667,547 B2Meshaberase, LLC
- Natural aqueous film-forming composition based on a pair of starches1 Oct 2026US 2026/0294815 A1Swiss Applied Coating Research GmbH
- Oral administration composition, soft capsule formulation and method for producing oral administration composition24 Sep 2026US 2026/0283994 A1Suntory Holdings Limited
- Coated enteric softgel capsules17 Sep 2026US 2026/0272844 A1R.P. Scherer Technologies, LLC
- Combination herbal medicines for the treatment of inflammatory bowel disorders3 Sep 2026US 2026/0256868 A1Evinature Ltd.
- Crystalline forms and formulations of a kras inhibitor3 Sep 2026US 2026/0258055 A1Eli Lilly and Company
Most cited
By later US patents
- Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents342US 6,309,663 B1Lipocine Inc. · 2001
- Oral compositions of proteinaceous medicaments303US 5,206,219 AApplied Analytical Industries, Inc. · 1993
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Clear oil-containing pharmaceutical compositions containing a therapeutic agent235US 6,761,903 B2Lipocine Inc. · 2004